These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23328675)

  • 1. Ghrelin counteracts salt-induced hypertension via promoting diuresis and renal nitric oxide production in Dahl rats.
    Aoki H; Nakata M; Dezaki K; Lu M; Gantulga D; Yamamoto K; Shimada K; Kario K; Yada T
    Endocr J; 2013; 60(5):571-81. PubMed ID: 23328675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats.
    Kataoka H; Otsuka F; Ogura T; Yamauchi T; Kishida M; Takahashi M; Mimura Y; Makino H
    Am J Hypertens; 2001 Mar; 14(3):276-85. PubMed ID: 11281241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High salt-induced weakness of anti-oxidative function of natriuretic peptide receptor-C and podocyte damage in the kidneys of Dahl rats.
    Zhu XL; Zhang T; Xu ZQ; Ma XC; Wang ZJ; Zou CW; Li JX; Jing HY
    Chin Med J (Engl); 2020 May; 133(10):1182-1191. PubMed ID: 32433050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension.
    Tan DY; Meng S; Manning RD
    Hypertension; 1999 Jan; 33(1 Pt 2):456-61. PubMed ID: 9931147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
    Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
    J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure reduction by Japanese traditional Miso is associated with increased diuresis and natriuresis through dopamine system in Dahl salt-sensitive rats.
    Du DD; Yoshinaga M; Sonoda M; Kawakubo K; Uehara Y
    Clin Exp Hypertens; 2014; 36(5):359-66. PubMed ID: 24047246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
    Louhelainen M; Merasto S; Finckenberg P; Vahtola E; Kaheinen P; Leskinen H; Levijoki J; Pollesello P; Haikala H; Mervaala EM
    J Physiol Pharmacol; 2009 Sep; 60(3):41-7. PubMed ID: 19826180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats.
    Ni Z; Oveisi F; Vaziri ND
    Hypertension; 1999 Oct; 34(4 Pt 1):552-7. PubMed ID: 10523325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal ghrelin receptor antagonism prevents high-fat diet-induced hypertension in male rats.
    Kemp BA; Howell NL; Gildea JJ; Padia SH
    Endocrinology; 2014 Jul; 155(7):2658-66. PubMed ID: 24797629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.
    Yamaleyeva LM; Lindsey SH; Varagic J; Zhang LL; Gallagher PE; Chen AF; Chappell MC
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):529-38. PubMed ID: 22370956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage.
    Altara R; da Silva GJJ; Frisk M; Spelta F; Zouein FA; Louch WE; Booz GW; Cataliotti A
    Hypertension; 2020 May; 75(5):1195-1204. PubMed ID: 32200677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary sodium intake and urinary dopamine and sodium excretion during the course of blood pressure development in Dahl salt-sensitive and salt-resistant rats.
    DeFeo ML; Jadhav AL; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(12):2049-60. PubMed ID: 3436080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium supplementation increases sodium excretion and nitric oxide production in hypertensive Dahl rats.
    Zhou MS; Nishida Y; Yoneyama H; Chen QH; Kosaka H
    Clin Exp Hypertens; 1999 Nov; 21(8):1397-411. PubMed ID: 10574420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a high-salt diet on hepatic atrial natriuretic peptide receptor expression in Dahl salt-resistant and salt-sensitive rats.
    McCartney S; Cramb G
    J Hypertens; 1993 Mar; 11(3):253-62. PubMed ID: 8097749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal nitric oxide synthase-deficient mice have impaired renin release but normal blood pressure.
    Sällström J; Carlström M; Jensen BL; Skøtt O; Brown RD; Persson AE
    Am J Hypertens; 2008 Jan; 21(1):111-6. PubMed ID: 18091753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a link between salt-intake and atrial natriuretic peptide system during hypertension induced by nitric oxide blockade?
    Marchi Alves LM; Tosi LR; Antunes-Rodrigues J; Cárnio EC
    Regul Pept; 2004 Aug; 120(1-3):127-32. PubMed ID: 15177930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
    Bae EH; Ma SK; Lee J; Kim SW
    Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High blood pressure enhances brain stem neuronal nitric oxide synthase activity in Dahl salt-sensitive rats.
    Tandai-Hiruma M; Kato K; Kemuriyama T; Ohta H; Tashiro A; Hagisawa K; Nishida Y
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):197-204. PubMed ID: 23278407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.